beta 25-35 alters calcium homeostasis and induces neurotoxicity in cerebellar granule cells

Area of Science:

• Neuroscience
• Cell Biology
• Neurodegeneration

Background:

• Amyloid beta fragments are implicated in neurodegenerative diseases.
• Cerebellar granule cells are vulnerable to various insults.
• Understanding mechanisms of neurotoxicity is crucial for therapeutic development.

Purpose of the Study:

• To investigate the neurotoxic effects of beta 25-35 amyloid fragment on cerebellar granule cells.
• To elucidate the intracellular mechanisms, particularly calcium homeostasis, involved in beta 25-35 neurotoxicity.
• To assess the interaction between beta 25-35 and glutamate toxicity in cerebellar granule cells.

Main Methods:

• Primary cultures of cerebellar granule cells at different in vitro days (DIV) were treated with beta 25-35.
• Cell survival was assessed under varying potassium chloride (KCl) concentrations.
• Glutamate-induced toxicity was evaluated in control and beta 25-35 pretreated cells.
• Intracellular calcium ([Ca2+]i) changes following glutamate stimulation were measured using calcium imaging.

Main Results:

• Beta 25-35 significantly reduced survival in low KCl conditions (5 mM) but had minimal effect in high KCl (25 mM).
• Pretreatment with beta 25-35 potentiated glutamate-induced neurotoxicity in both undifferentiated and differentiated cerebellar granule cells.
• Beta 25-35 altered glutamate-induced calcium ([Ca2+]i) influx, leading to a sustained plateau phase.
• Differentiated cells showed increased sensitivity to glutamate toxicity, further enhanced by beta 25-35.

Conclusions:

• Beta 25-35 exerts significant neurotoxic effects on cerebellar granule cells.
• The neurotoxicity is linked to dysregulation of intracellular calcium homeostasis.
• Beta 25-35 exacerbates glutamate excitotoxicity, suggesting a role in combined neurodegenerative pathways.